Through the stake sale, Canada Pension Plan took home about Rs 256 crore. At the end of March quarter, it held 1.47% equity in the company. In separate deals, Capital group affiliate Hema CIPEF has sold 0.46% stake in Mankind Pharma for Rs 2,082 apiece, taking the total deal value to Rs 385 crore.
from Stocks-Markets-Economic Times https://ift.tt/CxR4P7T
Home »
Stocks-Markets-Economic Times
» Block deals: Canada Pension Plan sells 0.5% in Nykaa for Rs 256 cr; Hema CIPEF offloads 0.46% in Mankind Pharma
Block deals: Canada Pension Plan sells 0.5% in Nykaa for Rs 256 cr; Hema CIPEF offloads 0.46% in Mankind Pharma
Related Posts:
Embedded as a risk, new Covid cycle could challenge Fed, recoveryAnalysts still expect economic growth in 2021 to be the strongest since 1984, but are now again mining real-time data for signs the Delta variant is changing behavior. from Stocks-Markets-Economic Times https://ift.tt/3iGPoV… Read More
Indiamart Q1 results: Net profit rises 19% to Rs 88 croreRevenue from operations rose 19 per cent to Rs 182 crore during the reported period, compared to Rs 153 crore in the corresponding quarter of 2020-21. from Stocks-Markets-Economic Times https://ift.tt/3zoyh15 … Read More
UltraTech reports a 114% jump in PAT at Rs 1,703 in Q1Net sales at the Aditya Birla Group flagship climbed 54 per cent to Rs 11,698 crore, fuelled by pent-up demand and a low statistical base. It recorded a volume growth of 48 per cent. from Stocks-Markets-Economic Times https:… Read More
NSE-BSE bulk deals: Maven India Fund sells stake in ANI Integrated ServicesIn another transaction, Cresta Fund bought 529,708 shares of Vishal Fabrics at Rs. 100 apiece through a bulk deal on the NSE. from Stocks-Markets-Economic Times https://ift.tt/3i3AOrT … Read More
JSW Steel reports Rs 5,900 crore of PAT in Q1 of FY 22Revenue from operations more than doubled to Rs 28, 902 crore as against Rs 11,782 crore. JSW Steel’s total expenses were at Rs 20,804 crore, up 66% year-on-year. from Stocks-Markets-Economic Times https://ift.tt/3rxCA7n … Read More
0 Comments:
Post a Comment